CPM
ONC

Connective Portfolio Management’s BeOne Medicines Ltd ONC Stock Holding History

Connective Portfolio Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000
Closed -$440K – 56
2022
Q4 		$440K Buy
+2,000
New +$367K 0.94% 40

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Connective Portfolio Management's ONC Position: Q1 2023 in Review

Connective Portfolio Management sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 2,000 shares — an estimated $440K sold.

Connective Portfolio Management first reported a position in ONC in Q4 2022 and held it in 1 quarter. The position peaked at $440K in Q4 2022. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Connective Portfolio Management reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Connective Portfolio Management sold 2,000 BeOne Medicines Ltd shares in Q1 2023, an estimated $440K.
  • Connective Portfolio Management first reported a position in BeOne Medicines Ltd in Q4 2022 and held it in 1 quarter.
  • Connective Portfolio Management's BeOne Medicines Ltd position peaked at $440K in Q4 2022.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Connective Portfolio Management's 13F filing for Q1 2023, filed 17 Apr 2023.